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Background: Alcohol misuse and dependency are major health problems worldwide. 
Despite the availability of a number of evidence-based treatments for alcohol-dependency, 
a large proportion of people relapse following detoxification. The costs to society and the 
individual are vast, not only economically but in terms of social and interpersonal 
functioning also. There is a recognised need to understand the factors that contribute to 
poorer outcomes in this population. Cognitive impairment is one factor that has 
demonstrated considerable associations with poor outcomes in the wider substance-
misuse population. 
Aims: This thesis has two sections. The first comprises a systematic review which aimed to 
present the objective evidence for emotional decision-making deficits in the alcohol 
dependent population. The second is an empirical study which aimed to establish whether 
or not relapse can be predicted in a severely alcohol dependent population in the early 
stages following inpatient detoxification. In addition, a normative dataset for this clinical 
population using the ACE-III is presented. 
Methods: For the systematic review, a structured search of the literature relating to 
emotional decision-making in alcohol dependent samples was conducted. Iterative 
application of pre-defined inclusion and exclusion criteria identified eighteen studies for 
critical review. Quality assessment of these studies was undertaken and validated by means 
of calculating inter-rater reliability. For the empirical study, two sub-samples of a cross-
sectional group of patients being treated for severe alcohol-dependence were examined; 
one to collate normative data for the ACE-III (N=73) and one to investigate associations 




Results: The systematic review demonstrated substantial support for a deficit in emotional 
decision-making ability in alcohol-dependence. Methodological quality of the reviewed 
papers was moderate to high. Deficits in performance on a task of emotional decision-
making compared to healthy controls indicated a reduced learning curve in alcohol 
dependent samples. Limitations of the studies included failure to report power analyses 
and effect sizes, insufficient detail regarding methodology and exclusion of common 
comorbidities in alcohol-dependence. The empirical study demonstrated clinically 
significant cognitive impairment in a sample of severely alcohol dependent individuals in 
the early stages following detoxification. In a smaller sample, cognitive functioning was not 
found to be predictive of relapse at one-month post-detoxification. Associations were 
identified between age and ACE-III score and between age and relapse status. Age was not 
predictive of outcome.  
Conclusions: The available evidence points towards the existence of emotional decision-
making deficits in alcohol dependent individuals. These are likely to impact on the ability of 
individuals make the health behaviour changes required to recover from alcohol 
dependence. Further research may be helpful in identifying factors associated with 
increased decision-making deficit in this specific population and investigating the processes 
underlying such difficulties. The clinical normative dataset presented in the empirical study 
points towards generalised cognitive impairment during the early stages of abstinence 
which may negatively impact on ability to engage meaningfully with psychosocial 
interventions. Performance on the ACE-III was not found to predict relapse in the current 
sample. Previous research would suggest that the links between cognitive functioning and 
relapse are less well defined in alcohol-misusing samples than in the wider substance-
misuse population. Therefore future research may help to clarify this association in alcohol 
dependent samples. It is acknowledged that the ACE-III is yet to be validated for use in the 
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alcohol dependent population and is limited in its ability to assess executive functions. 
Given the high prevalence of executive functioning deficits in the alcohol dependent 
population, it seems of importance to use cognitive screening tools which place appropriate 
emphasis on these abilities. Service providers are encouraged to incorporate routine 
cognitive screening into clinical practice and consider the implications of cognitive 
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Background: The evidence base for emotional decision-making deficits in alcohol 
dependency is well established. The aim of this review was to collate objective evidence 
from studies of decision-making using the Iowa Gambling Task (IGT) in alcohol dependent 
(AD) samples, to offer an indication of the methodological rigour of these studies, and to 
consider avenues for future research in this area.  
Method: A comprehensive search strategy resulted in the systematic review of 18 studies 
investigating emotional decision-making ability in alcohol dependent populations. Quality 
ratings indicated the studies to be of moderate to high quality overall. 
Results: Of 17 studies comparing AD samples to healthy controls, 12 reported poorer 
performance in the AD sample in overall IGT performance.  Support was also found for a 
reduced level of improvement across the blocks of the task in AD participants. Evidence for 
factors influencing decision-making ability in this group was wide-ranging and 
demonstrated mixed results. History of conduct disorder and presence of antisocial 
personality traits may contribute to decision-making deficits in some AD individuals. 
Conclusions: The available evidence points towards the existence of emotional decision-
making deficits in AD individuals. The relevance of assessing this ability in alcohol 
dependence is discussed and the implications for clinical practice considered. Suggestions 
are made for future research.  
 




Alcohol misuse and dependency are major health problems worldwide. It has been 
estimated that in 2004 3.8% of deaths were attributable to alcohol, with the highest 
proportion of these in the European region (Rehm et al. 2009). From an economic 
perspective, the costs to society in relation to loss of productivity, healthcare and law 
enforcement are vast (Rehm et al., 2009). The implications for an individual’s social and 
occupational functioning are striking, as the compulsion to obtain alcohol persists despite 
negative consequences for the individual and those around them. It is this repeated pattern 
of apparently poor decision-making that forms one of the so-called ‘hallmarks’ of addiction, 
including alcohol-dependency (American Psychiatric Association, 1994). In a review of the 
literature, Sher et al. (2005) outlined a number of factors potentially involved in the 
etiology of alcohol use disorders; including the areas of epidemiology, genetics, personality, 
neuropsychology, parenting and social factors. One particular alcohol-related condition that 
remains poorly conceptualised is alcohol-related brain damage (ARBD).  
 
1.2.1 Alcohol-Related Brain Damage 
ARBD is a term used to describe functional and structural changes to the brain as a result of 
long-term consumption of alcohol at harmful levels (Cox et al., 2004). These changes are 
thought to be the result of a combination of factors, including toxicity of alcohol on the 
brain, nutritional deficiency, cerebrovascular disturbances and head injury (Kopelman et al., 
2009; Thomson et al., 2012). ARBD itself is not a formal diagnosis, but deficits of this nature 
are considered to be subsumed within two related diagnoses in the ICD-10: Amnesic 
Syndrome due to alcohol (f10.6) and Alcohol related dementia (f10.73) (Word Health 
Organisation, 1992). ARBD is a heterogeneous condition with a wide variety of 
presentations, however it is widely accepted that impairments in memory and executive 
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functioning are present in most people (Bates et al., 2002). Whilst alcohol has been 
demonstrated to affect numerous brain regions, and overall brain volume and integrity (for 
review see e.g. Rosenbloom & Pfefferbaum, 1995), one area that appears to be particularly 
vulnerable to the effects of alcohol is the frontal cortex (Ratti et al., 2002; Chanraud et al., 
2007).  
 
1.2.2 Frontal lobes  
As a result of its complexity and links with almost all of the other components of the central 
nervous system (Moselhy et al., 2001), the frontal cortex is understood to serve as the 
neural substrate for a wide range of cognitive functions; often collectively termed as 
‘executive functions’. Research evidence indicates that the brains of alcohol dependent 
individuals are smaller than those of healthy non-alcoholics. For the most part, this 
shrinkage is believed to be the result of reduced white matter volume as opposed to loss of 
grey matter, or cortical tissue (Harper et al., 1985 and de la Monte, 1998; both cited in 
Harper, 1998). The frontal lobes in particular suffer from greater volume loss in comparison 
to other brain regions. In a review of alcohol-related brain damage, Harper (1998) 
suggested that this may be the result of the higher proportion of white matter compared to 
grey matter in this region. However decreases in grey matter have also been identified in 
the frontal lobes of alcohol dependent individuals by use of MRI (Chanraud et al., 2007). A 
number of researchers have investigated the basis for reduced brain volume. From a 
neurobiological perspective, many of the effects of alcohol on the brain are thought to be 
resultant of the effects of alcohol on various neurotransmitter systems, such as glutamate, 
aspartate, GABA, noradrenaline, dopamine and serotonin (De Witte et al., 2003). With 
repeated exposure to alcohol, these systems adapt accordingly to account for the chemical 
changes within the brain environment. As a result, during any period of withdrawal, the 
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concentrations of some of these neurotransmitters within the brain can increase, leading to 
toxicity and, ultimately, cell death (Weiss & Porrino, 2002).  
 
1.2.3 Executive functioning 
In his model of frontal lobe functioning, Stuss (2011) asserted that executive functioning 
constitutes ‘higher order’ functioning which serves to control and oversee more automatic 
cognitive functions. It is these processes that afford humans the ability to plan, organise 
and problem solve. Thus, whilst an individual may be able to effectively compensate for a 
deficit in a primary cognitive function if frontal lobe functioning is intact, deficits in more 
fluid abilities, such as the executive functions, are likely to result in widespread difficulties 
in day-to-day life (Lezak, 2004). In a review of frontal lobe functions, Moselhy et al. (2001) 
reported that despite preserved general cognitive functioning, people who misuse alcohol 
often demonstrate deficits in executive functioning (cognitive flexibility, problem solving, 
abstract reasoning, visuo-motor coordination, learning, conditioning, and memory) (pp. 
362-363). Research would also suggest that whilst functioning, on the whole, has been 
shown to improve with abstinence, executive dysfunction appears to remain (e.g. Chanraud 
et al., 2007; Nakamura et al., 2014). Executive functioning deficits have long been 
associated with difficulties maintaining sobriety from alcohol and also poorer outcomes 
following treatment for substance misuse (Goldstein & Volkow, 2002 and Moselhy, 2001; 
respectively). It is therefore unsurprising that much research has focused on understanding 
the role of executive functioning in the development and maintenance of substance 





1.2.4 Decision-Making Ability 
As mentioned, substance dependency is a disorder characterised by compromised decision-
making processes (Jeste & Saks, 2006). In his model of frontal lobe functioning, Stuss (2011) 
made a distinction between four conceptually distinct components: task setting, task 
monitoring (both thought to rely largely on the dorsolateral prefrontal cortex), emotionally 
driven behavioural control involved in the recognition of rewards (ventromedial prefrontal 
cortex; VMPFC), and metacognition including goal-directed behaviour and self-awareness 
(frontal poles).  From this perspective, deficits in decision-making could conceivably result 
from a breakdown of any combination of these sub-systems of executive functioning. In the 
context of addictions, where individuals may repeatedly make decisions in favour of 
immediate reward despite negative future consequences, the role of emotionally driven 
behavioural control seems of particular relevance. Therefore, for the purposes of the 
current review, the focus of discussion will be on decision-making which implicates such 
processes.  
 
1.2.5 The Iowa Gambling Task 
The Iowa Gambling Task (IGT; Bechara et al., 1994) is a widely-used, computerised, 
behavioural paradigm designed to assess decision making abilities, developed for use with 
patients with VMPFC lesions. It is an implicit gambling task; that is, one in which the 
contingencies of each choice are unknown to the participant and therefore decisions must 
be made under conditions of uncertainty. Participants are instructed to gain as much 
imaginary money as possible by making 100 selections from four decks of cards (A, B, C, D). 
With each card choice, the participant either gains or loses money. Each deck differs in the 
size of reward and penalty, but also in frequency of punishment. Of the four decks, A and B 
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are considered ‘risky’ or disadvantageous decks (high immediate gain followed by high 
penalty), choices from which will eventually lead to a net loss. C and D are considered 
advantageous and lead to an overall net gain (low immediate gain followed by low penalty) 
(Bechara, Tranel & Damasio, 2000). This schedule of reward vs penalty is unknown to the 
participant.  
 
A number of outcome measures may be calculated from the IGT, including number of 
choices from each deck, number of advantageous choices, number of disadvantageous 
choices and monetary outcome. Within the literature to date, the most commonly used 
outcome is the net score, which is the number of cards selected from advantageous decks 
minus those from disadvantageous ones. Another common outcome measure is to look at 
performance across different stages of the task. Use of the total net score alone may 
overlook relevant patterns in performance and learning effects that may be evident as the 
participant’s familiarity with the task increases. Given that alcohol use has been associated 
with neuropsychological deficits, including impairment of memory and aspects of new 
learning (Bates et al., 2002), this outcome measure is thought to be of particular relevance 
for the current review (see appendix 2 for further detail relating to measurement of 
outcome in the IGT). The IGT is thought to be ecologically valid and simulates real-life 
decision-making situations which typically involve elements of uncertainty, reward and 
punishment (Bechara et al., 1994; Bechara et al., 2000).  
 
Findings from studies using the IGT in populations of people with VMPFC lesions highlighted 
a tendency for this group to persist in making disadvantageous choices, despite explicit 
feedback regarding the losses incurred (Bechara et al., 2000). This pattern of performance 
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has come to be termed ‘myopia for the future’ (Bechara et al., 2000, p298) and has also 
been demonstrated in studies of substance-misusing populations (e.g. Bechara & Damasio, 
2002; Bechara et al., 2002). It has been suggested that this pattern of persistent 
disadvantageous decision-making in substance-dependent individuals (SDIs) is underpinned 
by deficits in emotional signalling systems in the brain. Originally described by Damasio 
(1994; cited in Verdejo-Garcia & Bechara, 2009), ‘somatic markers’ are an emotional 
mechanism associated with previous experience of situations that allow for anticipation of 
the outcome of a new, ambiguous situation. The somatic marker model of addiction 
proposes that, in SDIs, hyperactivity in the amygdala or ‘impulsive system’ may serve to 
increase the salience of immediate rewards; whilst underactivity in the prefrontal cortex or 
‘reflective system’ reduces the ability to look forward to the future consequences of a given 
action (Verdejo-Garcia & Bechara, 2009). Therefore, in situations of ambiguity – as 
considered to be measured by the IGT – SDIs have reduced capacity to inhibit behaviours 
which will lead to immediate reward. As with other executive functions, evidence would 
suggest that impairment in decision-making ability may persist even following years of 
abstinence (e.g. Fein et al., 2004). 
 
1.2.6 Decision-Making Deficits in Alcohol Dependence 
The clinical relevance of characterising the nature of decision-making deficits in the alcohol 
dependent (AD) population is clear, considering that it may constitute a mechanism by 
which certain individuals are at increased risk of developing and maintaining substance use 
problems (Miranda et al., 2009). With a more sophisticated understanding of these deficits, 
policy, assessment and care planning for this group may be able to be tailored to their 
specific profile of strengths and weaknesses. Clinicians are often asked to comment on the 
capacity of patients with alcohol-use disorders to make reasoned judgements regarding 
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their welfare and finances (Hazelton et al., 2003). As has been highlighted, this is one 
particular area where this population may be at a distinct disadvantage; although preserved 
functioning in other cognitive domains (e.g. ‘functional reorganization’ hypothesis posited 
by Pfefferbaum et al., 2001), personality traits or coping styles (Ando et al., 2012) may 
serve to conceal or compensate for such difficulties. From a treatment perspective, 
evidence suggests a link between better decision-making ability and increased motivation 
to change drinking behaviour at treatment entry (Le Berre et al., 2012). In addition, 
concerns regarding response to treatment were highlighted by Tomassini et al. (2012), who 
further raised the possibility that decision-making deficits in this population may lead to 
increased interpersonal difficulties and risk of harm to self or others. With the potential for 
such wide-ranging implications, increased understanding of deficits in decision-making in 
alcohol-dependence is of great importance and may impact on the emphasis given to 
assessing ‘hot’ decision-making abilities (Brand et al., 2007), as are engaged in ambiguous 
situations.  
 
Brevers et al. (2014) make reference to the relative wealth of research into poor decision-
making under conditions of ambiguity in alcohol dependence as a rationale for expanding 
the evidence-base for the related concept of risky decision-making. It therefore seems 
prudent to assimilate the findings in relation to this particular area. Zorlu et al. (2013a) 
highlight a number of methodological challenges in interpreting the findings of such 
research owing to the high degree of poly-substance misuse and other comorbidities in the 
experimental samples. Arguably, inclusion of such groups is reflective of the presentations 
of most AD populations. However their inclusion leads to difficulties interpreting any 
findings. Furthermore, polysubstance abuse has been reported to result in poorer 
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performance on the IGT compared to abuse of any individual substance (Grant et al., 2000; 
Rotheram-Fuller, 2004). In relation to comorbidity, there is a large amount of research 
which points toward decision-making deficits across a number of psychiatric and medical 
conditions (for a summary, see Buelow & Suhr, 2009). Therefore, it seems of relevance to 
try to summarise the findings in relation to emotional decision-making ability in as ‘pure’ an 
AD population as possible to try to establish the relative contributions of this particular 
disorder – or pre-existing impairments in people who go on to develop alcohol-dependence 
– to the impairments described in the literature.  
 
In a review of behavioural decision-making and neuroimaging studies, Dom et al. (2005) 
described consistent decision-making impairment in patients with substance-use disorders 
(SUDs) across eleven studies which focused on behavioural decision-making paradigms. Ten 
of these studies used the IGT. Whilst this review provided substantial evidence in support 
of impaired decision-making in SUDs, the findings must be interpreted in light of the 
following limitations. Firstly, the review included a wide variety of substance misuse 
samples (amphetamines, opiates, poly-drug misuse, alcohol, methadone, ‘substance use 
disorder’, and ‘substance dependency’) and one VMPFC lesion sample. The severity of 
dependency for most of these groups was not clear, nor was the presence of comorbid use 
of other substances in addition to the main substance of misuse. This variation in samples 
makes the assimilation of findings somewhat difficult, limiting the ability to generalise to 
any given substance-misuse population. Furthermore, the study characteristics would 
suggest that the samples varied in their duration of abstinence and ongoing use of 
prescribed maintenance substances, which may have influenced decision-making ability. 
Finally, the review only reported the findings from one study of AD participants. In light of 
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the range of evidence to suggest that AD individuals are impaired in tasks of emotional 
decision-making ability and to build on the findings from the aforementioned review, the 
aim of the current systematic review was to describe and evaluate the evidence for an 
objective deficit in emotional decision-making ability in adults with alcohol-dependency. 
 
1.3 METHOD 
1.3.1 Literature search strategy 
The electronic literature search was conducted in June/July 2014. It was not feasible to 
translate texts from other languages, therefore searches were limited to studies published 
in English. Other limits included human-only studies and studies of adult participants 
(18+yrs). The Cochrane Database of Abstracts of Reviews of Effects (DARE) was consulted to 
ensure that a similar review had not recently been conducted.  
 
Four electronic databases were searched, from the disciplines of health and psychology: 
PsycINFO (1987 to June week 4 2014), EMBASE (1980 to 2014 week 26), OvidMEDLINE(R) 
(1946 to June week 3 2013) and CINAHL Plus. Searches were performed using default 
‘multi-purpose’ fields and included title, abstract, subject heading and keyword. For all 
databases, the following keyword search was employed: [alcoholi* OR alcohol* adj3 
depend* OR alcohol* adj3 addict* OR alcohol* adj3 abus*] AND [decisi* adj mak* OR 
ventromedial prefrontal cortex OR gambl* adj3 task*].  
 
Two journals which regularly publish on cognitive impairment in relation to substance 
misuse were hand-searched online for relevant papers since 2004: ‘Alcoholism: Clinical and 
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Experimental Research (Vol. 28, issue 1 to Vol. 38, issue 7)’ and ‘Alcohol and Alcoholism 
(Vol. 39, issue 1 to Vol. 49, issue 4)’. Reference lists of the studies included in the current 
review were also searched for relevant papers. 
 
1.3.2 Data collection and analysis 
References were selected by the main author using an iterative approach, involving a 
number of ‘screens’ of the data. With each screen, the inclusion and exclusion criteria were 
systematically applied and items removed according to these (as detailed in Table 1). 
Following an initial removal of duplicates, articles were screened for suitability by title and 
abstract. The remaining 71 articles were reviewed in full, resulting in the exclusion of 53 
studies (see Appendix 3 for details and reasons for exclusion). The remaining 18 studies 
were included in the current review. See Figure 1 for an outline of the search results and 
selection process. 
 
Table 1- Inclusion and Exclusion Criteria for studies 
Inclusion Criteria 
1. Primary empirical papers reporting on quantitative data 
2. Studies that examined populations of adults aged 18-65yrs  
3. Studies that examined participants meeting recognised criteria for alcohol 
dependence  
4. Studies which used the Iowa Gambling Task (IGT) as a measure of emotional decision-
making ability 
5. Studies which measured decision-making in terms of risky performance 
Exclusion Criteria 
1. Studies not published in English 
2. Case studies, unpublished dissertations, or review articles 
3. Articles which were not peer reviewed 
4. Studies which measured performance on the IGT in terms of reaction time or 
biological/physiological outcomes 
5. Studies where participants are known have a significant history of or current 
dependence to other drugs (i.e. meet diagnostic criteria for two or more substances), 




1.3.3 Assessment of Methodological Quality 
A checklist was devised, informed by the aims of the review, to assess the methodological 
quality of each included study. The final checklist items were based on the SIGN (Scottish 
Intercollegiate Guidelines Network) 50 Methodology Checklist 4 for case control studies 
(SIGN, 2011; pp67-72) and CONSORT guidelines (2010). Using the checklist, each paper 
could score a maximum of 19 points (see Appendix 4). Each paper was rated initially by the 
lead author. The papers were then rated by a second author and Cohen’s kappa statistic 
indicated substantial agreement between the raters, Kappa=.806 (95% CI, .741 to .871). 
Discrepancies were resolved through discussion. Based on arbitrary cut-offs, studies were 




















Flow diagram adapted from: Moher et al. (The PRISMA Group, 2009). 
  
Databases searched: 
CINAHL - 50 
EMBASE - 654 
MEDLINE - 474 
PsycINFO - 332 
 
Total records identified: N=1510 
14 additional records identified 
through other sources 
Screened by title/abstract: 
1031 
66 full text articles accessed 
for eligibility 




Excluded by title/abstract: 
965 
Excluded due to 
inclusion/exclusion criteria: 49 
Screened by abstract: 14 
Excluded by abstract: 9 
5 full text articles accessed 
for eligibility 
1 studies included in 
qualitative synthesis 
Excluded due to 
inclusion/exclusion criteria: 4 
Total studies: 18 




1.4.1 Study Characteristics 
Study demographic information, quality ratings and key outcomes relating to the IGT are 
presented in Table 2. Studies differed by country of origin and therefore utilised various 
translations of the original IGT. Most articles reported modest sample sizes, with number of 
AD participants ranging from 17 (Zorlu et al., 2013b) to 58 (Fein et al., 2006). Most studies 
were mixed-gender, with 5 including only men. Duration of abstinence at the time of 
testing ranged from 0 days (active drinkers; Fein et al., 2006) to over six years (Ando et al., 
2012; Fein et al., 2004). Seventeen of the reviewed articles adopted a case-control design, 
comparing AD samples to non-alcohol dependent healthy controls (HC). Ando et al. (2012) 
was the only study not to include a control group; instead comparing a sample of ADs in 
short-term abstinence (mean 12 weeks) to those in longer-term abstinence (mean 327 
weeks).  
 
1.4.2 Methodological Review 
Only two studies achieved high quality assessment ratings (Cordovil et al., 2010 and 
Miranda et al., 2009), with the majority (n=15) rated moderate. Only one met less than 50% 
of the quality criteria assessed (Kim et al., 2006). A number of studies lost marks in relation 
to insufficient information to rate the item as positive; this was the case especially for items 
related to recruitment, exclusion criteria, comparability of control groups with 
experimental groups and description of methodology. It is therefore difficult to comment 
on a number of potential sources of bias in these areas. However, it is possible that these 
items are reflective of poor reporting quality rather than methodological weaknesses. Final 
quality ratings for each paper can be seen in Appendix 5.  
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1.4.3 Narrative Review 
The following comprises a narrative review of findings derived from the search strategy 
outlined in Figure 1. Only findings related to the IGT are reported. The results will be 
presented in two sections. Firstly, findings in relation to IGT performance in alcohol 
dependent subjects compared to healthy controls will be described. Secondly, findings in 
relation to IGT performance between subgroups of AD samples will be presented. Any 
additional findings which have examined other variables in relation to IGT performance in 
alcohol dependent samples will be summarised in this section.  
 
1.4.3.1 IGT Performance – Alcohol Dependent (AD) versus Healthy Controls (HC) 
Of the 17 studies which included a control group, 12 (70.59%) reported significantly poorer 
overall IGT performance in the alcohol dependent sample compared to controls (Brevers et 
al., 2014; Cordovil et al., 2010; Fein et al., 2004; Goudriaan et al., 2005; Kim et al., 2006; 
Kim et al., 2011; Le Berre et al., 2014; Miranda et al., 2009; Noel et al., 2007; Noel et al., 
2011; Salgado et al., 2009; Tomassini et al., 2012). Thirteen papers commented on 
performance by block or stage of the task, with 11 (84.61%) reporting poorer performance 
in AD samples compared to controls on one or more of the five blocks of the IGT (Brevers et 
al., 2014; Cordovil et al., 2010; Kim et al., 2006; Kim et al., 2011; Le Berre et al., 2014; 
Miranda et al., 2009; Noel et al., 2007; Noel et al., 2011; Salgado et al., 2009; Tomassini et 
al., 2012; Zorlu et al., 2013b). Two identified no group by block differences (Goudriaan et 
al., 2005; Loeber et al., 2009). Healthy controls were found to perform better than AD 
participants in block two in two studies (Salgado et al., 2009; Tomassini et al., 2012), block 
three in three studies (Kim et al., 2006; Kim et al., 2011; Miranda et al., 2009), block four in 
six studies (Cordovil et al., 2010; Kim et al., 2006; Kim et al., 2011; Salgado et al., 2009; 
Tomassini et al., 2012; Zorlu et al., 2013b) and block five in nine studies (Kim et al., 2006;  
17 
 
Table 2- Study Demographic Information, Quality Ratings and Key Outcomes 
Study, country and quality 
rating 
Population and sample 
Size 
(n =) 
Groups matched for: Average Abstinence 
Duration: mean(sd) 
IGT Total/Overall Performance: difference observed? 
(yes/no) 
 
d = Cohen’s d (where reported or able to be 
calculated) 
IGT Performance by block  
 
Difference observed? (yes/no) 










(STA) – 43 
Gender 
IQ 








No (STA vs LTA)  
 
Both groups consistently performed at chance level. 
There was no significant difference between groups. 
 
Yes (both STA and LTA) 
 
No learning effect observed for 
either group 





AD – 21 
HC – 20 
 21days No (AD vs HC) 
 
Yes (relapsed AD vs abstinent AD) 
 
Not reported 






HC:  30 
Age  
Years of education 
Gender 
22.07days(3.49) Yes (AD vs HC) 
 
AD made significantly more disadvantageous 
decisions overall 
Yes (AD vs HC) 
 
AD showed no improvement 
across blocks whilst HC did 
 
Significantly poorer choices on 
blocks 3, 4 and 5. 





AD – 35 (split into two 
for the analysis of IGT 
outcomes) 






Time point 1 – 0-
1days 
 
Time point 2 – 14-
18days 
Yes (AD vs HC) 
 
AD made more disadvantageous choices: 
- d (t1) vs HC = 0.71 
- d (t2) vs HC = 1.01 
 
and accrued lower net scores compared to controls: 
- d (t1) vs HC = -0.69 
- d (t2) vs HC = -0.96 
 
No (recently abstinent AD vs longer abstinent AD)  
- d (t1) vs (t2) = -0.22 
Yes (AD vs HC) 
 
Only significant difference 
between AD and controls at 
block 4 (controls scored higher): 
 
- d (t1 and t2) compared to 
HC = > 0.66 
 
No (AD t1 vs AD t2) 




AD – 43  
HC – 58 
Age 





Yes (AD vs HC) 
 





Study, country and quality 
rating 
Population and sample 
Size 
(n =) 
Groups matched for: Average Abstinence 
Duration: mean(sd) 
IGT Total/Overall Performance: difference observed? 
(yes/no) 
 
d = Cohen’s d (where reported or able to be 
calculated) 
IGT Performance by block  
 
Difference observed? (yes/no) 
15/19 (Minimum 6 
months) 
- d = -0.52 (calculated using data published in 
Fein et al., 2006) 





AD (Treatment naïve) – 
58 





Actively drinking No (AD vs HC) 
 
- d (AD vs HC) = -0.16 
 
No  (Tx naïve AD vs abstinent AD)  
 
- d (TxN AD vs Abst) = 0.33 
Not reported 





AD – 46 
HC – 49 
Gender 
IQ 
3-12months Yes (AD vs HC) 
 
AD chose less cards from the advantageous decks 
compared to controls: 
- d = 0.67 
 
No (AD vs HC) 
 
AD performance did improve 
across trials but AD selected 
‘good’ decks less frequently than 
controls. No interaction between 
group and block was present 
between AD and HC. 
 





AD – 56 (28 with history 
of CD, 28 without) 
HC – 40 (10 with history 
of CD, 30 without) 
Age 
Gender (all male) 
 
Minimum 2 weeks Original IGT 
Yes  (AD CD- and AD CD+ vs HC CD-) 
No (AD CD- and AD CD+ vs HC CD+) 
 
AD patients as a whole showed impaired DM 
compared to HC CD- but not compared to HC CD+ 
 
No (AD CD- vs AD CD+) 
 
No difference was observed between AD CD- and AD 
CD+. 
 
Variant IGT  
No (AD vs HC or AD CD+ vs AD CD-) 
 
Original IGT Block 3 
Yes (AD CD+ and HC CD+ vs HC 
CD-) 
No (AD CD- vs HC CD-) 
 
HC CD+ and AD CD+ (but not AD 
CD-) performed worse than HC 
CD- in block 3 
 
Blocks 4 & 5 
Yes (whole AD sample and HC 
CD+ vs HC CD-) 
 
AD CD +, AD CD- and HC CD+ 
performed worse than HC CD- in 





Study, country and quality 
rating 
Population and sample 
Size 
(n =) 
Groups matched for: Average Abstinence 
Duration: mean(sd) 
IGT Total/Overall Performance: difference observed? 
(yes/no) 
 
d = Cohen’s d (where reported or able to be 
calculated) 
IGT Performance by block  
 
Difference observed? (yes/no) 
No  
 
No group differences existed but 
overall improvements were seen 
across the whole sample as task 
progressed. No group by block 
interaction was observed. 





AD – 23 
HC – 21 
Age 
Gender (all male) 
IQ 
2 weeks Yes (AD vs HC) 
 
AD patients performed poorly on IGT compared to 
HC: 
d = 1.27 
d (deckA) = 0.74 
d (deckB) = 0.93 
d (deckC) = -0.73 
d (deckD) = -0.94 
 
 
Yes (AD vs HC) 
 
AD demonstrated impaired DM 
on the IGT compared to HC on 
blocks 3-5  
 
 





AD – 30 
HC(DM) – 45 
HC(imag) - 27 
Age  






Yes (AD vs HC) 
 
ADs selected more high-risk cards than controls. 
 
d (total IGT)= 0.52 
d (deckA) = -0.24 
d (deckB) = 1.26 
d (deckC) = -1.06 
d (deckD) = 0.09 
 
Yes (AD vs HC) 
 
AD made significantly poorer 
choices in block 5 compared to 
HC 





AD – 48 
(AD Lo Detox – 27; AD Hi 
Detox – 21) 







range – 4-37 
No (AD vs HC) 
 
No difference was observed on overall IGT 
performance between whole AD sample and controls 
 
Yes (Hi Detox vs Lo Detox) 
 
No (AD vs HC) 
 
Both groups (AD and HC) showed 
a similar degree of improvement 
across blocks 
 




Study, country and quality 
rating 
Population and sample 
Size 
(n =) 
Groups matched for: Average Abstinence 
Duration: mean(sd) 
IGT Total/Overall Performance: difference observed? 
(yes/no) 
 
d = Cohen’s d (where reported or able to be 
calculated) 
IGT Performance by block  
 
Difference observed? (yes/no) 
Hi Detox demonstrated poorer overall IGT 
performance compared to Lo Detox 
 
Yes (recently abstinent vs longer abstinent; post hoc 
analysis) 
 
Lo detox demonstrated a greater 
increase in advantageous choices 
across blocks compared to Hi 
Detox 





AD – 22 
AD + ASPD – 17 
HC – 21 
 AD – 
13.64months(21.34) 
AD + ASPD – 
13.56(21.65) 
HC – 10.2(19.83) 
 
Yes (AD and AD+ASPD vs HC) 
 
Overall AD and AD + ASPD groups performed worse 
than HC. 
 
No (AD vs AD+ASPD) 
 
Yes (AD vs HC) 
 
AD performed worse than HC at 
block 3  
 
Yes (AD+ASPD vs AD and HC) 
 
AD + ASPD performed worse than 
both controls and AD at block 5. 
 





AD – 30 




AD – 19.3days(2.5) 
(minimum 15days) 
HC – 2.1(1.4) 
Yes (AD vs HC) 
 
AD performed worse than controls by selecting more 
cards from disadvantageous decks.  
Yes (AD vs HC) 
 
AD performed significantly worse 
in block 5 of the IGT 





AD – 30 




AD – 19.3(2.5) 
HC – 2.1(1.4) 




Yes (AD vs HC) 
 
HC performed significantly better 
on the IGT at stage 5. 
 





AD – 31 
HC – 30 
Age 
Gender  
Years of education 
IQ 
15-120days (split 







Yes (AD vs HC) 
 
No (AD short-term vs AD long-term abstinence) 
 
 
Yes (AD vs HC) 
 
HC performed significantly better 




Study, country and quality 
rating 
Population and sample 
Size 
(n =) 
Groups matched for: Average Abstinence 
Duration: mean(sd) 
IGT Total/Overall Performance: difference observed? 
(yes/no) 
 
d = Cohen’s d (where reported or able to be 
calculated) 
IGT Performance by block  
 
Difference observed? (yes/no) 





AD – 27 




AD – 16.85months 
(13.21), minimum 
6months 




Yes (AD vs HC) 
 
HC performed significantly better 
in blocks 2, 4 and 5. Both groups 
demonstrated improvement over 
time, HC demonstrated more 
than AD. 





AD – 30 




Level of Education 
AD were recruited 
between days 20-30 
of inpatient 
treatment 




Not reported  





AD – 17 
HC – 16 
Age 
Years of education 
AD – 17.1 +/- 
1.8days 
 




Yes (AD vs HC) 
HC shifted their choices from 
disadvantageous to 
advantageous, particularly over 
the last two blocks whilst AD did 
not. 
 
AD performance was significantly 




Kim et al., 2011; Le Berre et al., 2014; Miranda et al., 2009; Noel et al., 2007; Noel et al., 
2011; Salgado et al., 2009; Tomassini et al., 2012; Zorlu et al., 2013b).  
 
As can be seen in Table 2, three of the studies which split their AD samples into subgroups 
analysed overall IGT performance in ADs without commenting on subgroup comparisons 
with controls (Bowden-Jones et al., 2005; Loeber et al., 2009; Salgado et al., 2009).  
 
One study investigated the influence of a history of conduct disorder (CD) on IGT 
performance in a group of AD participants and controls both with and without a history of 
CD (Kim et al., 2006). Net scores on the original IGT were found to be significantly lower in 
both AD samples compared to healthy controls without conduct disorder but not those 
with. There were no group differences observed on the variant IGT. In the original IGT, 
significant differences in performance were identified in blocks three, four and five. In block 
three, healthy controls without a history of CD chose more advantageously than AD 
participants with a history of CD, but not ADs without. In blocks four and five, healthy 
controls without a history of CD chose more advantageously than all other groups. In the 
variant IGT, a significant effect of block was found across the whole sample. No effect of 
group or group by block interaction was found, indicating that all groups demonstrated a 
similar rate of improvement in performance.  
 
In a study investigating the impact of antisocial personality disorder (ASPD) on decision-
making, the DM ability of thirty nine male AD participants was compared to that of 21 male 
controls (Miranda et al., 2009). The AD group was split into those meeting diagnostic 
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criteria for antisocial personality disorder (ASPD) and those who did not. Both AD groups 
were found to independently perform significantly worse than controls in the IGT (sum of 
net scores across all five blocks). In block three, the AD group without ASPD performed 
significantly worse than the control group, with no other differences reported for this block. 
In block five, the AD+ASPD group performed significantly worse than controls. No such 
difference was identified between AD without ASPD and controls. No group differences 
were identified for any other blocks. 
 
In addition to comparing performance on the IGT, two studies sought to assess participants’ 
explicit knowledge of which decks were risky and which were advantageous, demonstrating 
opposing findings. Goudriaan et al. (2005) assessed this at the end of the entire task and 
established that AD participants identified fewer decks correctly than controls. Miranda et 
al. (2009) assessed insight at the end of each of the five blocks and asserted that by the end 
of the task, there was no difference between AD participants and controls. 
 
1.4.3.2 IGT Performance – AD Subgroup Comparisons and Other Associations 
A number of studies compared subgroups of AD participants on their decision-making 
ability using the IGT, demonstrating a variety of findings. Attempts were also made to 
investigate relationships between other variables in AD samples and decision-making 
ability. The following sections will summarise findings in relation to these. In cases where it 
was not clear if the sample used in the analysis was just AD or included the whole sample, 





Duration of Abstinence 
Nine studies (50%) investigated different stages of abstinence in relation to IGT 
performance. Four included abstinence duration as a comparison in their main analysis, 
three of which found no significant difference in IGT performance between groups (Ando et 
al., 2012; Cordovil et al., 2010; Fein et al., 2006). The groups compared in these studies 
were average 12 weeks abstinence versus approximately six years, 0-1 days versus 14-18 
days, and 0 days versus average 6-7 years, respectively. In contrast with these findings, 
Loeber et al. (2009) compared performance in those who had maintained abstinence for 
less than 16 days with those who had remained abstinent for 16 or more and reported that 
recently abstinent patients accrued a significantly lower overall net outcome on the IGT 
compared to longer abstinent patients. Four studies investigated correlations between 
duration of abstinence and IGT performance (Fein et al., 2004; Le Berre et al., 2014; Salgado 
et al., 2009; Tomassini et al., 2012). None reported a significant association between these 
two variables. Bowden-Jones et al. (2005) retrospectively compared the IGT scores at 21 
days abstinence of AD participants who went on to relapse at three months versus those 
who remained abstinent. It was found that those who relapsed performed significantly 
worse overall on the IGT at the start of treatment than those who had remained abstinent. 
 
Other Alcohol use related variables 
Nine of the reviewed studies (50%) assessed other alcohol use-related variables and their 
association with IGT performance. Only one of these studies reported a significant 
association: Fein et al. (2004) found significant negative correlations between decision-
making ability and both duration of alcohol use and duration of peak use. However, only 
duration of peak use remained significant after controlling for the effects of age in the 
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sample. Duration of peak use was also examined in Fein et al. (2006), who found no 
association with IGT performance in their AD sample. Similar constructs were examined by 
Ando et al. (2012), Kim et al. (2006), Le Berre et al. (2014) and Zorlu et al. (2013a); all of 
whom reported no significant association with IGT performance. As can be seen in Table 2, 
a variety of other alcohol use-related variables were also considered in association with 
decision-making ability in the AD samples. None of these demonstrated significant 
associations. 
 
Personality, Temperament and mood 
Six studies explicitly reported associations between personality traits/temperament and IGT 
performance in AD participants. Correlations with scores on measures of socialisation and 
externalisation with IGT performance highlighted no significant association in one long-
term abstinent AD sample (Fein et al., 2004). Another study reported a significant 
association between ASPD diagnostic status and performance on the last three blocks of 
the IGT (Miranda et al., 2009). Further investigation of the sub-facets of ASPD failed to 
reveal associations between decision-making and degree of psychopathic traits but 
identified a significant inverse relationship between degree of anti-social personality traits 
with blocks three, four and five of the IGT. In a combined predictive model, they found the 
latter to mediate the difference in IGT performance between AD with ASPD and those 
without.  In a study comparing AD participants with and without a history of conduct 
disorder, no difference in net IGT (original version and variant) or score across the final two 
blocks was observed between AD groups (Kim et al., 2006). Novelty seeking and self-
reported tendency toward impulsivity have been negatively correlated with IGT 
performance (Noel et al., 2011 and Tomassini et al., 2012 respectively). Non-planning 
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impulsivity (or acting without forethought) was found to be associated with overall IGT 
performance and both non-planning and overall impulsivity (combining attentional, motor 
and non-planning) associated with block four, specifically. No association was identified 
between decision-making ability and depression (Loeber et al., 2009). 
 
Neuropsychological and Executive Functioning 
In relation to neuropsychological functioning, findings were mixed. Working memory was 
found to be positively correlated to IGT performance in one study (Fein et al., 2006) but no 
such association was found in another (Brevers et al., 2014). Similarly, set-shifting and 
perseveration were not found to be correlated with IGT performance in one study (Salgado 
et al., 2009) but Fein and colleagues (2006) identified a positive association between 
cognitive flexibility and decision-making. No correlations with IGT performance were found 
with dual tasking (Brevers et al., 2014) or motor impulsivity (Salgado et al., 2009). Number 
of categories produced in the Wisconsin Card Sorting Test was positively associated 
specifically with both block two and overall performance on the IGT in one study, whilst 
total errors and perseverative errors in the same task was negatively correlated with block 
two of the IGT (Kim et al., 2011). The same study identified a negative correlation between 
risky decision-making on the Game of Dice Task (a measure of explicit decision-making) and 
IGT block five. Response inhibition deficit was noted to predict impaired performance on 
the second half of the IGT in AD participants who achieved a net score of less than ten on 
the IGT (the best score of patients with VMPFC damage reported in Bechara et al., 2001) in 
one study (Noel et al., 2007). Considering other aspects of neuropsychological functioning, 
positive correlations were found between IGT performance and both delayed memory and 




Brain Functioning and Integrity 
Grey matter shrinkage, particularly in areas associated with decision-making, was found to 
be associated with poorer performance in the IGT (Le Berre et al., 2014). White matter 
integrity in the corpus callosum and left posterior cingulum was positively correlated with 
IGT performance in block 5 in another study, whilst no correlations were found between 
overall IGT performance and white matter integrity in any region for AD participants, 
despite various associations across the whole sample (Zorlu et al., 2013b). 
 
1.5 DISCUSSION 
1.5.1 Summary of Findings 
This systematic review investigated decision-making deficits in alcohol dependent 
individuals. Using a structured search strategy, 18 studies reporting decision-making ability 
using the IGT in an alcohol dependent population were identified. The majority of these (12 
of 17 eligible papers) identified a significant deficit in emotional decision-making in AD 
compared to controls across the entirety of the task. A majority also noted increased 
impairment compared to healthy controls as the task progressed (block 2 in two studies; 
block 3 in three studies; block 4 in six studies; block 5 in nine studies).  
 
Two studies compared subgroups of AD individuals to control participants in their main 
analysis; indicating that history of conduct disorder may adversely impact on decision-
making ability in both AD participants and controls and that comorbid ASPD may affect 
alcohol dependent individuals’ decision-making in the late stages of the IGT. A variety of 
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other associations yielded mixed findings. Socialisation and externalisation revealed no 
significant association with IGT performance whilst self-reported impulsivity and novelty 
seeking were negatively correlated. One study revealed no association between depression 
and IGT performance. Duration of abstinence was not generally found to be related to IGT 
performance (seven of nine studies reported no significant findings), and findings were 
similar for other alcohol use-related variables (one of nine studies found a significant 
association – duration of peak alcohol use – however, another study found no such 
association). Investigations of neuropsychological findings demonstrated conflicting 
findings regarding associations between IGT performance and both working memory and 
cognitive flexibility. No correlations were found for dual-tasking or motor impulsivity and 
IGT performance. Some aspects of executive functioning (generation of categories, 
perseveration, explicit decision-making ability and response inhibition deficit) have been 
associated with poorer performance on the IGT as were delayed memory and spatial 
processing. 
 
1.5.2 Context of Findings: Methodological Limitations 
A number of methodological factors may have influenced the results obtained in the 
studies reviewed. No studies reported a priori sample size calculations or confidence 
intervals for findings in relation to IGT performance. Whilst many reported statistically 
significant results, without an indication of the power of the analysis it is possible that those 
reporting non-significant findings were underpowered to detect any difference between 
experimental groups.  This seems particularly pertinent in the case of non-significant 
findings between subgroups of AD participants where differences may be more subtle and 
samples were often sub-groups of the larger group recruited. However, in the case of 
overall IGT performance compared to HC, sample sizes were comparable in those studies 
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that identified significant differences and those that did not. Had studies reported 
confidence intervals, it may have been possible to discern the degree of precision of the 
non-significant findings. In such instances where differences fail to meet statistical 
significance, differences that may be of clinical importance may fall within the bounds of 
confidence estimated. In the case of the current review, the risks of inadvertently accepting 
the null hypothesis are unlikely to result in any immediate harm. However, missing 
potentially clinically relevant information would seem to undermine the vast amount of 
research that has gone into this area to date. 
 
Another item that was poorly reported was effect size. It was however possible to calculate 
this in studies which provided sufficient information. Using Cohen’s conventional criteria 
for classifying size of effect (Cohen, 1992), the effect sizes obtained would suggest medium-
high effect sizes in comparisons between AD groups and controls (see Table 2). Effect sizes 
for comparisons of AD subgroups tended to be smaller, supporting the hypothesis that 
differences between AD subgroups may be more subtle.  
 
One area that seems of particular relevance when interpreting the current results is the 
degree of confound. In only 50% of papers was it deemed clear that exclusion criteria were 
the same for both cases and controls (with the obvious exception of the inclusion of 
alcohol-dependence/misuse for control groups). Alongside this, over a quarter of the 
papers provided insufficient detail to allow for a meaningful judgement of the 
comparability of the two groups. As can be seen in Table 2, controls were matched to AD 
groups on a number of variables; most commonly age (15 studies), education level (15 
studies) and gender (14 studies). Only five however, reported matching groups on IQ level. 
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Although intuitively it seems reasonable to suggest that measures of IQ and measures of 
decision-making may be associated, a recent literature review indicated that variance in 
performance on the IGT was not, in fact, explained by performance in tasks of executive 
functioning and general cognitive ability (Toplak et al., 2010). The authors suggest that 
decision-making ability may therefore be conceptually separate to these other processes. 
Consistent with this review, findings in relation to cognitive functioning and decision-
making in the current sample were variable, suggesting that these abilities may represent 
distinct processes in the alcohol dependent population also. Therefore failing to match 
groups on cognitive ability should not necessarily be viewed as a weakness. 
 
Only half of the reviewed papers provided sufficient detail about the method to allow for 
replication. In particular, a number failed to comment on the order of test administration or 
randomisation procedures. It is acknowledged that the effects of fatigue can impact 
negatively on people’s performance on standardised cognitive assessments (Lezak, 2004). 
Therefore, methods to control for such effects would be advisable in any study involving 
assessment of cognitive functioning, including decision-making. 
 
A number of studies excluded participants on the basis of current or previous Axis I mental 
health disorders (15 studies), Axis II disorders (two studies), traumatic or organic brain 
injury (15 studies) and significant physical health problems (13 studies). Whilst such 
exclusionary criteria are likely to reduce confounding factors and aid in the attribution of 
any findings to alcohol-dependence, such comorbidities are common in alcohol dependent 
populations (e.g. Morgenstern et al., 1997 and Swendsen et al., 1998). Furthermore, it is 
noted from studies in the current review that have included comorbid populations (e.g. Kim 
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et al., 2006 and Miranda et al., 2009), that the decision-making deficits in the AD 
population may be mediated by comorbid mental health conditions. Therefore, to exclude 
participants on these grounds substantially reduces the generalisability of findings to the 
wider alcohol dependent population. 
 
1.5.3 Limitations of Review 
Owing to resource constraints, only papers published in English were included in this 
review. This limits the scope of research accessed and influences any findings in favour of 
Western societies. As the search was limited prior to reviewing, it is not possible to 
comment on how many non-English articles were excluded. As with any review, the 
selection process is likely to have incorporated a degree of selection bias. This may have 
been increased by the development of a unique quality rating measure. The degree of 
inter-rater reliability however was good, suggesting that at least in the interpretation of 
items assessed, variability was minimal. All of the studies in this review were of a case-
control design. The observational nature of such designs relies on adequate control of 
confounding variables. As noted, it is difficult to know how well this was achieved in the 
reviewed studies. Such designs also lend themselves to potential spurious claims of 
causation. The IGT manual warns against inferring substance misuse-related frontal lobe 
damage when using the measure in substance-dependent populations (Bechara, 2007 cited 
in Buelow and Suhr, 2009). It is not possible from this type of study to tell the temporal 
sequence between, in this instance, alcohol-dependence and decision-making deficit.  
 
Another potential limitation of this review was to restrict to studies of only the IGT. Unlike 
other implicit measures of decision-making (e.g. the Balloon Analogue Risk Task; Lejuez et 
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al., 2002) the IGT is considered to potentially measure two different types of decision-
making: decision making under ambiguity and decision-making under risk. It was 
considered that this may allow for more sophisticated understanding of decision-making 
deficits as they present in this population. The incidence in some studies of reporting only 
overall or ‘net’ outcomes for the total IGT may reduce the construct validity of the measure 
(Buelow and Suhr, 2009). The studies reviewed here utilised this outcome measure either in 
isolation or alongside block or stage comparisons and therefore the findings using the 
former must be considered with this caveat.  
 
Finally, it could be argued that a number of the items on this measure relate more to 
reporting quality than methodological quality (items 1, 3, 4, 9, 11, 14-19). Subsequently, 
some studies are likely to have been marked up or down for issues that do not necessarily 
reflect the ability of the study to address the review question. The rationale for including 
these items was largely owing to recognition that the reader can often only assess the 
methodological rigour of empirical studies based on the information provided in the article. 
Therefore, to effectively and critically appraise research articles, consistency and 
transparency of reporting is of great importance (see www.consort-statement .org). A 
published review of quality assessment systems echoed the importance of good reporting 
of evidence in empirical research and highlighted what the author deemed to be ‘critical’ 
items to be included in rating tools (Lohr, 2004). The ratings used in the current review 
reflect the relevant items in this publication. However, it is acknowledged that mere 
omission of information does not necessarily equate to methodological weakness. The 
items for the current checklist were collated using items from existing rating systems for 
quality of reporting (CONSORT, 2010) and methodological rigour (SIGN 50, 2011). Three 
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additional items (4, 6 and 16) were added by the author to reflect areas of importance to 
the studies included in the current review. By including only those items which relate to 
methodological quality (items 2, 5-8, 10, 12 and 13), the ratings of each of the papers 
included in the current review may more accurately reflect the ability of these to address 
the review question without the confound of reporting quality. 
 
1.5.4 Research Implications 
Overall, the findings suggest a consistent impairment in decision-making under ambiguity, 
using the IGT, in adults with alcohol-dependence. This was in keeping with findings from 
studies of other clinical populations who demonstrate similar real-life decision-making 
deficits; such as pathological gamblers, people with OCD, schizophrenia, ADHD, 
psychopathy, HIV, Huntington’s Disease, Parkinson’s Disease and eating disorders (Buelow 
and Suhr, 2009). This would suggest that the IGT is effective at detecting such impairments 
in an alcohol dependent population. However, the findings in relation to AD subgroups 
were less consistent. Therefore, it is recommended that further research into subgroups of 
alcohol dependent individuals be carried out with sufficient sample size to detect what may 
be subtle differences in performance and perhaps begin to uncover particular risk-factors 
for increased decision-making deficit in this heterogeneous population.  
 
As aforementioned, the construct of decision-making as measured by the IGT may be better 
assessed by considering the early versus late stages of the task. Brand et al. (2007) referred 
to selections in the early phase of the IGT as decisions under ambiguity and those in the 
late phase as decisions under risk. In the earlier blocks, participants are unaware of the 
contingencies attached to each deck but, as the task progresses, they begin to learn these 
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and therefore to make decisions with more explicit understanding of the potential for loss. 
These processes have come to be known as ‘hot’ decision-making (under ambiguity and 
consistent with the somatic marker hypothesis) and ‘cold’ decision-making (under risk). 
Therefore, decisions at different stages of the task may be considered to be using different 
processes of decision-making. The findings of the current review would seem to support 
this conceptual split of the phases of the task as, overall, the deficit observed between AD 
groups and controls became greater as the task progressed. Therefore, it is possible that 
risky decisions made by AD individuals in the latter phase of the task indicate a more 
rational, ‘cold’ decision-making deficit. Therefore, research into the conceptual differences 
of the phases of the IGT in AD may be helpful in isolating the particular deficits in this 
population and informing more sophisticated approaches to care and treatment.  
 
1.5.5 Clinical Practice Implications 
Decision-making deficits are considered one of the hallmarks of addiction. Understanding of 
the processes underpinning these is essential in helping to break the destructive cycle of 
relapse. The findings would suggest benefit from providing support to AD individuals during 
any formal decision-making process, such as decisions related to welfare and finances. 
Given the possibility that AD individuals are less able to make use of ‘gut instinct’ or 
somatic markers, any process that serves to elucidate the options – and associated benefits 
or drawbacks of each – to the individual, may be of some assistance. Consistent with this 
idea, a systematic review of neuropsychological rehabilitation in ARBD suggests potential 
benefit of rule provision strategies in helping to provide structure during problem-solving 
situations (Svanberg & Evans, 2013). However, as discussed, even with explicit knowledge 
of potential loss and gain associated with decision-making situations, people with AD may 
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still struggle to make the advantageous choice. With regards to clinical or therapeutic input, 
a number of interventions related to relapse prevention involve elements of decision-
making (e.g. decisional balance in Motivational Interviewing techniques, Miller and Rose, 
2013). Patients must also make day-to-day decisions in relation to lifestyle choices and 
independent living which inevitably involve aspects of reward and consequence. It seems 
likely from the current review that people with AD may benefit from additional support in 
these tasks and perhaps assistance with planning for the future in a bid to overcome the 
temptation to resort to prepotent responses.  
 
Furthermore, it may be of value for individuals with AD to acknowledge what may be 
considered to be a biologically-driven explanation for some of the difficulties they 
experience. The ‘disease model’ of addiction, for example, suggests that by seeing addiction 
as an illness the individual may learn to use the help available to them and to live in spite of 
their difficulties rather than strive to be rid of them (Cook, 1988). The findings of this review 
would suggest that decision-making deficits may be long-standing in this population and it 
is possible that they even pre-date problematic alcohol use. Therefore, for some, being able 
to identify with this may not only normalise their experience but also facilitate them in 
seeking support to manage their addiction. 
 
1.5.6 Conclusions 
This systematic review of decision-making deficit, as measured by the IGT, in an alcohol 
dependent population demonstrates that within the current literature there is considerable 
support for decision-making deficits in AD. Support was also found for a reduced level of 
improvement across the task in AD, which may be interpreted as a shift towards risky 
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decision-making. Evidence for factors influencing decision-making ability in this group was 
wide-ranging and demonstrated mixed results. History of conduct disorder and presence of 
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Background: Much research has evidenced the negative impact of cognitive impairment on 
outcomes following treatment for addictions. Research specifically into alcohol-misusing 
populations is less consistent. The aims of the current study are to compile a normative 
dataset for a clinical sample of severely alcohol dependent adults in the early stages of 
abstinence, using the ACE-III cognitive screen, and to investigate the ability of the ACE-III to 
predict risk of relapse following treatment for alcohol dependence. 
Methods: The current clinical sample was compared to existing normative data for the ACE-
III. Predictive models were developed using relevant covariates to investigate the 
contribution of cognitive status to relapse at one-month. 
Results: The study identified substantial cognitive impairment in a severely alcohol 
dependent population in the early stages following inpatient detoxification. No association 
was found between gender and ACE-III performance. Negative correlations were found 
between age and total ACE-III, memory, verbal fluency and visuospatial domains. 
Performance on the ACE-III was not predictive of relapse at one-month post-discharge. 
Associations were found between age and ACE-III score and between age and relapse. Age 
did not predict relapse. 
Conclusions: These findings suggest that, following one week of abstinence, alcohol 
dependent individuals may exhibit a substantial degree of global cognitive impairment. 
Impairment did not however predict relapse in the current sample at this time. It is 
suggested that the ACE-III may not be sensitive to the full profile of cognitive impairment 
often seen in alcohol dependence. Limitations of the current study, implications for 
research and clinical practice are discussed. 





Alcohol dependence has been described as a chronic and relapsing condition (e.g. 
Stockwell, 1999). Many patients with alcohol dependence will relapse within one year of 
treatment (65-70%), with most relapsing within three months (e.g. Miller & Hester, 1986; 
Miller, Walters & Bennett, 2001). Various factors affecting relapse have been identified 
including depressive symptoms (Suter et al., 2011); anxiety (Willinger et al., 2002); self-
efficacy (Blomqvist et al., 2003); gender (Zwyiak et al., 2006) and cognitive functioning 
(Morrison, 2011). Conversely, engagement with addictions treatment has been consistently 
associated with a favourable treatment outcome in substance use disorders (SUDs) 
(Brorson et al., 2013). In their systematic review of studies looking at risk factors for drop-
out from addictions treatment, Brorson and colleagues identified the most consistent risk 
factors as cognitive deficits, low treatment alliance, personality disorder and younger age.  
 
With such a range of variables impacting on the outcome of treatment for alcohol 
dependency, it is of great importance for specialist services to consider their approach to 
assessing and treating this problem. National government guidelines for the treatment of 
alcohol dependency highlight the importance of a comprehensive assessment which 
includes – amongst other things – assessment of readiness and belief in the ability to 
change; cognitive functioning; degree of dependence and psychological problems (NICE, 
2011). Many treatments for alcohol dependence endorse a focus on relapse prevention and 
this is reflected in the Scottish Intercollegiate Network Guidelines (p 16; SIGN 74, 2003), 
which state that access to established relapse prevention treatment should be facilitated 
for all patients dependent on alcohol. With drop-out from treatment having clear 
ramifications for alcohol dependent individuals (and their wider networks), including 
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contributing to relapse, consideration of factors which may contribute to continued 
engagement with treatment services must also play a part in any process of assessment and 
treatment.  
 
Given the vast scope of potential contributors to outcome in this population, it is 
unsurprising that a great deal of research has gone into identifying which of these factors is 
most predictive of relapse and/or drop-out from treatment. With regards to drop-out in 
particular, the recent review by Brorson et al. (2013) demonstrated that cognitive 
impairment would appear to be the most consistently associated with poor outcome in the 
field of substance misuse. A significant amount of research shows that harmful alcohol use 
can lead to impairments in cognitive function (e.g. Tapert et al., 2001). Such impairment 
can arise as a result of various factors, such as the direct result of the toxic effect of alcohol 
on the brain’s neurophysiology (Oscar-Berman et al., 1997), injuries acquired as a result of 
intoxication (e.g. head injury; Galbraith et al., 1976), and even from the toxic effects of 
alcohol withdrawal (e.g. ‘excitotoxicity’, De Witte et al., 2003) and associated 
complications, such as withdrawal seizures (Loeber et al., 2010). Morrison (2011) found 
that specific cognitive impairments may also be seen as predictors of relapse, in particular, 
executive functioning. This has clear implications for the process of recovery from alcohol 
dependence and is further complicated by the fact that many of the interventions that are 
suggested for the management of harmful alcohol dependence – such as psycho-education 
and cognitive behavioural therapy (NICE, 2011) – require the development of skills which 




As a result of the high prevalence of cognitive impairment in the alcohol-misusing 
population, the National Institute for Health and Clinical Excellence (2011) recommends 
that cognitive functioning be assessed as part of a comprehensive assessment when adults 
are referred to specialist alcohol services. This, however, presents a number of challenges 
to the care provider. Firstly, it is well established that cognitive functioning is often 
impaired on commencing detoxification due to the aforementioned toxic effects of alcohol 
and withdrawal on the neurophysiology of the brain. Therefore assessing someone in the 
early stages of detoxification is likely to give a misrepresentation of their baseline abilities. 
Cognitive functioning has been found to improve following a few weeks of abstinence 
(Bates et al., 2002), with the greatest return of functioning happening within the first week 
(Ryan & Butters, 1986 cited in Lezak, 2004). It is generally recommended that cognitive 
assessment take place after 3-6 weeks of abstinence (Lezak, 2004). From a practical 
perspective however, there are difficulties in achieving this degree of abstinence in many 
patients with alcohol dependence. Whilst cognitive assessment carried out in the initial 
stages of detoxification may not provide an accurate longer-term estimate of functioning, it 
may provide valuable information about the patient’s current level of functioning and 
subsequent ability to participate and engage in treatment. This may be one of the few 
opportunities available during which treatment may be offered. Furthermore, given time 
pressures on clinical staff, it is of relevance that any screening tool be time-efficient and 
suitable for use by a wide range of clinicians. There is evidence to suggest that cognitive 
impairment can affect both treatment outcomes (e.g. Fals-Stewart, 1993) and the ability to 
adhere to treatment programmes (Bates et al., 2006). Therefore, the impact of cognitive 
impairment, frequency with which it is observed in the alcohol dependent population and 
its potential role in contributing to poorer outcomes supports the consideration and 




Scottish Intercollegiate Guidelines Network (SIGN; 2003) guidelines highlight the need for 
simplified screening tools that help identify the issues that affect patients with alcohol 
dependence; however, there are very few brief, cognitive screening tools that have been 
validated for use with an alcohol dependent population. NICE (2011) suggest that the ACE-R 
(Addenbrooke’s Cognitive Examination – Revised; Mioshi et al., 2006) may be sensitive 
enough to identify mild cognitive impairments in people who misuse alcohol. The ACE-R has 
been validated in a wide variety of populations including individuals with brain injury 
(Gaber, 2008); fronto-temporal dementia, Alzheimer’s disease, mild cognitive impairment 
(Bak & Mioshi, 2007) and Parkinson’s disease (Reyes et al., 2009). Developed as an 
‘extended MMSE’ (Mini Mental State Examination; Folstein et al., 1975 – also suggested by 
NICE for use in screening for cognitive impairment in alcohol misuse), the original ACE was 
developed to cover a wide spectrum of cognitive functioning: attention and orientation, 
memory, fluency, language, and visuospatial abilities (Mioshi et al., 2006). Despite the 
tool’s apparent sensitivity in detecting impairment in the above populations, there does not 
appear to have been any research carried out looking at the use of the ACE-R with an 
alcohol dependent population. The ACE-R has recently been updated to the ACE-III due to 
copyright issues related to the MMSE, which formed part of the ACE-R screening tool (Hsieh 
et al., 2013). The opportunity was also taken to modify some of the items which had 
presented relative weaknesses in the measure with a view to strengthening the tool’s 
sensitivity and validity. Similar to its predecessor, there does not appear to have been any 




2.2.1 Aims of the Study 
There is clearly a role for the effective identification of cognitive impairment in patients 
entering treatment for alcohol dependence. There is also sufficient justification for 
investigating brief, cognitive screening tools to identify such impairment of functioning. In 
2007, The Scottish Government published a strategy document for the provision of care 
and support for people with co-occurring substance misuse and mental health problems 
(‘Commitment 13’, The Scottish Government, 2007). This document highlights the potential 
value of cognitive screens in forming part of a comprehensive assessment of alcohol-
related brain damage (ARBD). The ACE-R had no normative data for the substance-misusing 
population; this is currently also the case for the ACE-III. Given the use of the tool in this 
population and its endorsement in national guidelines, it seems pertinent to be able to 
compare an individual’s score to a more clinically-relevant data-set, allowing for potentially 
more meaningful comparisons to be made and to inform care planning. The aims of this 
study therefore are to present a normative dataset for the ACE-III in an alcohol dependent 
population (Part I) and to establish whether the ACE-III can identify those patients who are 
at most risk of drop-out from treatment and/or relapse (Part II). As a result of variations in 
data availability for each participant, Parts I and II of the current study involve different sub-




The present study was part of a larger service evaluation within the host site looking at the 
range of presentations and outcomes for those attending for inpatient detoxification from 
substance dependency. In the current study, only data from alcohol dependent (AD) 
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patients were used. Data were collected from November 2013 to August 2014. A total of 
186 viable datasets were collected over this time period for people entering the clinic for 
alcohol detoxification. Of this number, 136 participants met inclusion criteria for the 
current study (see Table 1): 97 males (71.3%) and 39 females (28.7%). The average age was 
47(±9.1) years for this particular cohort and average length of admission was 11.4 days 
(max. 30 days; 85% staying between 7 and 14 days). Participants who reported concurrent 
substance use in addition to alcohol were included in the analysis owing to the high degree 
of such substance use patterns in AD individuals (Staines et al., 2001). The inclusion criteria 
were designed to be as broad as possible to maximise the ecological validity of any findings.  
 
Table 1 – Reasons for Exclusion 
Reason for Exclusion Number of 
Participants 
Patient admitted for any reason other than, or in addition to alcohol detoxification 
(e.g. opiate conversion/reduction or respite) 
10 
History of traumatic brain injury 2 
Known or queried intellectual disability 1 
Formal diagnosis of alcohol-related brain damage 2 
Unstable opioid use 8 
Inpatient stay of less than 7 days 21 
Formal diagnosis of polysubstance abuse 3 
Invalid datasets (issues relating to comprehension of items on measures) 3 
Total 50 
 
All participants met ICD-10 (World Health Organisation, 1992) classification for alcohol 
dependence and were deemed ‘severely’ dependent (as outlined in SIGN 74 guidelines, 
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SIGN, 2003) by virtue of their requirement for an inpatient detoxification, as opposed to 
community-based alternatives.  
 
Two sub-samples were used for the separate parts of this study; N=73 for Part I and N=20 
for Part II (see Table 2). All patients received treatment as usual: a reducing regime of 
benzodiazepine therapy to manage their withdrawal symptoms in combination with 
vitamin B therapy and a menu of psychosocial interventions including an inpatient group 
programme and access to a multi-disciplinary team. Dosage and duration of medications 
was varied depending on individual needs. Patients typically stay between seven and ten 
days for an alcohol detoxification. 
 
Table 2 – Demographic and Patient Characteristics 
Characteristic Sample for Part I (N=73)a Sample for Part II (N=20)b 
Age – mean(SD) 46.83(9.25) 44.15(7.78) 
Gender - % Female 34.2% 40% 









Opioid Dependence 4.1% 5% 
Benzodiazepine Dependence 9.6% 15% 
Mood Problems 56.2% 65% 
Anxiety Problems 21.9% 15% 










Concurrent Illicit Drug Use 23.3% 20% 
a Sample comprised those datasets which included complete ACE-III data.  
b Sample comprised those datasets which included data for all predictor and outcome variables. 
 
Explicit consent was not sought from participants in relation to the current study since 
patients consent to the use of their clinical data in relation to audit and service evaluation 
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at the point of admission. This was carried out in line with local policy and procedure and 
approval was granted for such use of data by the local Caldicott Guardian (see Appendix 6). 
Ethical approval was granted by the Ethics Committee at the School of Health in Social 
Science, University of Edinburgh (see Appendix 7). Informal advice was sought from a 
representative of the South East Scotland Research Ethics Service, who confirmed that the 
project constituted a service evaluation and therefore did not require NHS ethical review. 
 
2.3.2 Procedure 
As part of routine clinical practice, all patients were assessed by ward staff on admission to 
the clinic. Because previous research has identified a relationship between age, mood and 
anxiety with treatment outcomes, these formed the predictor variables in the current 
study. Alongside these variables, the importance of assessing readiness to change has been 
highlighted and was therefore included in the analysis. It is acknowledged that other 
variables have the potential to influence outcomes following treatment for alcohol-
dependence (see Adamson et al., 2009 and Brorson et al., 2013 for systematic reviews). 
Owing to practical constraints on the current project – specifically, that data were collected 
in line with routine clinical practice – it was not feasible to include other potential 
confounders. Given the exploratory nature of the study however, this was deemed 
satisfactory. 
 
Information regarding patient age, mood, anxiety and motivation was routinely collected as 
part of a clinical interview at the time of admission. At a minimum of seven days following 
admission, and therefore seven days of abstinence, all patients attending for alcohol 
detoxification were invited to take part in an ACE-III assessment by a member of the ward 
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staff. It was not possible or clinically appropriate to assess all patients at precisely seven 
days following admission owing to variations in individual needs and clinical practicality. It 
was decided, in keeping with recommendations from clinical neuropsychological literature, 
that data would be viable for the current project so long as the ACE-III took place at a 
minimum of seven days abstinence from alcohol (that is, seven days from the point of 
admission). 
 
All routinely collected data were entered into an excel database. Only the information 
relevant to the current study was extracted to conduct relevant analyses. Follow-up data 
were obtained via email to patient keyworkers sent by the lead clinician for the clinic.  
 
2.3.3 Measures 
2.3.3.1 Mood and Anxiety 
The presence of a comorbid mood or anxiety disorder was assessed via three sources: 
clinical interview on admission (nursing and medical review), clinical assessment during 
inpatient stay, and whether or not the patient was using anti-depressant medication at the 
time of admission. It is widely acknowledged that alcohol misuse has a depressant effect 
and therefore it is impossible at this early stage of treatment to know whether mood 
disorder – separate to that caused by alcohol use – is, in fact, present (Davidson, 1995). 
Furthermore, research would suggest that most anxiety and depression resolves with 
standard treatment for alcohol problems (see SIGN 74, 2003). In light of this, it was not 
deemed viable to introduce formal mood or anxiety measures into routine practice. 
Therefore, the proxy measures noted above were adopted for the current study. If an 
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individual met any one of the three above-noted criteria, mood or anxiety disorder was 
coded as present. 
 
2.3.3.2 Motivation 
The Revised Readiness to Change [Treatment Version] Questionnaire (RCQ[TV]) is a twelve-
item, self-report measure of motivation to change drinking behaviour (Heather & 
Hönekopp, 2008). Based on the transtheoretical model of health behaviour change 
(Prochaska et al., 1992), the items in the questionnaire are designed to assess which stage 
of change the client is at, at the point of administration: pre-contemplation, contemplation 
or action. Each item features a statement related to the client’s beliefs about their drinking 
behaviour. They respond using a five-point Likert scale, ranging from ‘strongly disagree’ to 
‘strongly agree’, with scores for each item ranging from -2 to +2. Four items relate to each 
of the stages of change and therefore a total score for each stage may be calculated; with 
the highest score denoting the stage of change the client is thought to be at (quick scoring 
method; Heather et al., 1999). Although this measure is self-report, assessing clinicians 
assisted clients in its administration to ensure completeness and help reduce issues related 
to literacy and comprehension. 
 
The RCQ[TV] has demonstrated good internal consistency across the three subscales and 
good construct validity, as established by strong correlations with measures of alcohol use 
and alcohol-related problems (Heather & Hönekopp 2008) and between RCQ[TV] subscales 
and a measure of negative outcome expectancies for alcohol treatment. The authors also 
reported significant relationships between stage of change as measured by the RCQ[TV] 
and treatment outcome at three and 12 months, suggesting the predictive validity of the 
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tool. The internal consistency of the subscales in the current study were assessed for the 
sample used in Part II, demonstrating reasonable reliability (pre-contemplation: N=4, 
α=.794; contemplation: N=4, α=.714; action: N=4, α=.723). 
 
2.3.3.3 Cognitive Functioning 
The Addenbrooke’s Cognitive Examination III (ACE-III; Hsieh et al., 2013) is a revised and 
updated version of the widely-utilised Addenbrooke’s Cognitive Examination Revised (ACE-
R) (Mioshi et al., 2006). The tool assesses five cognitive domains: attention, memory, 
language, fluency and visuospatial abilities. The tool is scored out of 100, with higher scores 
denoting better cognitive functioning. Domain-specific scores may also be calculated and 
compared with published norms for a healthy older adult population (n=25; Hsieh et al., 
2013). Hsieh and colleagues demonstrated a strong correlation (r=0.99) between the ACE-III 
and its predecessor. They also reported that the domain scores achieved medium to high 
correlations with neuropsychological tools commonly used in the assessment of dementia, 
suggesting good construct validity. The sensitivity and specificity of the tool in relation to 
dementia remain high relative to the cut-off scores suggested by the original authors 
(88/100 and 82/100, respectively), with its internal reliability proving robust (Cronbach’s 
alpha coefficient = 0.88). 
 
2.3.3.4 Relapse 
In line with other research looking at outcomes following treatment for substance misuse, 
it was originally planned that drinking outcomes would be measured in three ways: 
cumulative days of abstinence, time to first drink and number of days drinking. However, it 
was not possible to obtain this information at four-week follow-up and therefore the 
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dichotomous variable of ‘relapsed’ versus ‘abstinent’ was utilised instead. The operational 
definition of relapse in this instance would include any return to alcohol, as reported by the 
participant’s keyworker. Where participants failed to engage with treatment – and also in 
line with other research (e.g. Schneekloth, 2012) – they were presumed relapsed.  
 
2.3.3.5 Engagement 
Following discharge from the clinic, patients are allocated a keyworker. The outcome 
measure for engagement was originally planned to be a proportion of appointments 
attended compared to those offered, calculated as a percentage. However, due to limited 
information and variability in follow-up data returned, it was decided that a dichotomous 
variable of less than 50% versus 50% or more would be adopted. Following an investigation 
of the descriptive characteristics of this sample, it was identified that this variable had no 
variability, with all 20 participants attending 50% or more appointments offered. It was 
therefore removed from further analysis.  
 
2.3.4 Statistical Analysis 
Statistical analyses were performed using the IBM Statistical Package for Social Sciences 
(SPSS), Version 22 (IBM SPSS, 2013). For Part I of this study, mean scores and standard 
deviations were calculated for the total ACE-III score and its subdomains. Shapiro-Wilk test 
of normality indicated non-normal distributions, therefore Mann Whitney U tests were 
used to compare ACE-III scores between males and females and Spearman’s Rho 
correlations were used to examine associations between age and ACE-III. For Part II, 
descriptive statistics (means, standard deviations and frequencies) were used to describe 
the characteristics of the smaller sample. Tests of normality indicated that age and ACE-III 
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total score distributions did not deviate significantly from a normal distribution so 
independent samples t tests were used to examine differences in age and ACE-III score 
between those who relapsed at four weeks post-discharge and those who had not. Chi 
square analysis was used to investigate differences between the categorical predictor 
variables (mood, anxiety, motivation) in relation to relapse status. Logistic regression was 
used to examine the relative contribution of the predictor variables to relapse status. Using 
the conventional method for sample-size calculation in regression analysis (reported in 
Green, 1991): N ≥ 50 + 8 m; it is estimated that a sample size of greater than 90 participants 
would be required to meet statistical power in the current analysis.  
 
2.4 RESULTS 
2.4.1 Part I: Clinical Normative Data 
The cohort used to compile the normative dataset consisted of 73 alcohol dependent 
individuals aged between 23 and 72 years. Of these participants, 48 were male. With 
regards to other substance use, 3 individuals were known to be opioid dependent but 
stable in their opioid use and 7 were benzodiazepine dependent. Fifty-two reported no 
concurrent use of other substances at the time of their assessment. The remainder 
reported varying types and degrees of substance use. 
 
The alpha coefficient of the ACE-III in this study was 0.82, which is comparable to the values 
found for the original ACE-R (0.80; Mioshi et al., 2006) and the ACE-III (0.88; Hsieh et al., 
2013) and considered acceptable (Field, 2005). Table 3 presents domain and total ACE-III 
scores for the current sample alongside the normative data published using a sample of 25 
healthy older adults with an average age of 66.1 (SD=7.4; Hsieh et al., 2013). The table also 
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includes the ‘lower limit of normal’, calculated as described in the study of the earlier ACE-R 
(Mioshi et al., 2006), which was taken to be the total score minus two standard deviations. 
 









Hsieh et al. (2013) 
N=25 
17.4(1.2) 24.3(1.7) 12.5(1.4) 25.6(0.6) 15.6(0.6) 95.4(3.3) 
Lower limit of 
normal 
15 20.9 9.7 24.4 14.4 88.8 
Current study – 
Whole Sample 
(N=73) 
16.3(1.8) 20.0(4.4) 9.6(2.7) 23.5(2.3) 13.8(2.2) 83.2(10.1) 
Current study – 
Females (N=25) 
15.9(1.8) 20.3(4.8) 9.1(2.7) 23.1(2.3) 13.4(2.3) 81.8(11.1) 
Current study – 
Males (N=48) 
16.5(1.7) 19.9(4.2) 9.9(2.7) 23.7(2.3) 14.0(2.1) 83.8(9.6) 
 
As can be seen, the AD sample in the current study scored more than two standard 
deviations below the healthy normal sample on all domains except attention/orientation 
(<1SD below normative mean). For the memory and fluency domains, the clinical sample 
fell less than three standard deviations below the healthy control mean. For the 
visuospatial domain, scores fell exactly three standard deviations below the control mean 
and, for language, greater than three standard deviations. The largest deficit was observed 
for the overall score, where the clinical sample score fell 3.7 standard deviations below the 




2.4.1.1 Gender Differences on ACE-III Scores 
Mann Whitney U tests indicated no significant differences between males and females on 
ACE-III Total score (U=541.00, ns, r=-.08), Attention/Orientation (U=482.00, ns, r=-.17), 
Memory (U=567.50, ns, r=-.04), Verbal Fluency (U=467.00, ns, r=-.18), Language (U=495.50, 
ns, r=-.14) or Visuospatial domains (U=510.50, ns, r=-.12). 
 
2.4.1.2 Correlations between Age and ACE-III Scores 
There was a negative relationship between the age of participants and ACE-III Total score, 
rs=-.368, p=.001. A negative relationship was also found between age and scores for 
Memory (rs =-.384, p=.001), Verbal Fluency (rs =-.447, p<.001) and Visuospatial domains (rs 
=-.268, p=.0023). No relationship was identified between age and scores on 
Attention/Orientation or Language (both p>.05). 
 
2.4.2 Part II: Predictors of Outcome 
The sample used for Part II of this study comprised 20 alcohol dependent individuals aged 
between 23 and 56 years (average 44.2, SD=7.8). Twelve participants were male. One 
participant was opioid dependent and three were dependent on benzodiazepines. Four 
reported illicit drug use in addition to alcohol use.  
 
2.4.2.1 Associations between Predictor Variables and Relapse 
The difference between continuous predictor variables in relation to relapse status (relapse 
having two levels: 0=relapsed, N=7; 1=abstinent, N=13) was assessed using independent 
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samples t-tests. Relapsed individuals were significantly older (49.14±4.71 years) than those 
who remained abstinent at four weeks post-discharge (41.46±7.90 years), t(18)=2.341, 
p=.031. There was no significant difference in ACE-III score between those who relapsed 
(85.29±8.64) and those who remained abstinent (88.46±9.09), t(18)=-.758, p=.458. 
Differences in domain scores between those who relapsed and those who remained 
abstinent were also non-significant (attention: U=49.00, ns, r=-.06, memory: U=62.00, ns, 
r=-.30, fluency: t(18)=-0.223, p=.826, language: U=61.50, ns, r=-.29, visuospatial: U=42.00, 
ns, r=-.06). 
 
The difference between categorical predictor variables in relation to relapse status was 
assessed using Pearson’s chi-square test. No group differences were identified between 
mood and relapse, χ2=2.32, p=.128; anxiety and relapse, χ2=.00, p=.948; or motivation and 
relapse, χ2=.85, p=.357. 
 
2.4.2.2 Predictors of Relapse 
For exploratory purposes, despite low sample size, a logistic regression analysis was 
undertaken to predict relapse in this sample using age, mood, anxiety, motivation and ACE-
III score as predictors. A test of the full model against a constant-only model demonstrated 
statistical significance, indicating that the predictors – as a set – reliably distinguished 
between those who relapsed and those who remained abstinent (chi square = 17.963, 
p<.01, df=5). The model explained 81.6% (Nagelkerke’s R square) of variance in relapse and 
correctly classified 95% of cases. The Wald criterion demonstrated that no individual 




Because age was found to be associated with relapse, a separate logistic regression was 
undertaken to predict relapse using age as the only predictor variable. A test of the full 
model against a constant-only model demonstrated statistical significance of the model (chi 
square = 6.293, p<.05, df=1) which explained 37.2% (Nagelkerke’s R square) of variance in 
relapse and correctly classified 70% of cases. The Wald criterion demonstrated that age did 
not contribute significantly to the model (p>.05). 
 
2.5 DISCUSSION 
2.5.1 Summary of Findings 
The first aim of this study was to compile a normative dataset for an alcohol dependent 
population, using the ACE-III, following one week of abstinence. The clinical sample scored 
3.7 standard deviations below published norms on the ACE-III overall. Sub-domain scores 
also indicated reduced functioning compared to norms for all domains except 
attention/orientation, where the score fell within the normal range. Negative correlations 
were found between age and scores on overall ACE-III, memory, verbal fluency and 
visuospatial domains.  
 
The second aim of the study was to investigate the predictive capacity of the ACE-III in 
relation to engagement with treatment and relapse following inpatient detoxification. ACE-
III scores were not significantly different in those who relapsed compared to those who did 
not. Those who relapsed were older than those who did not. No associations were found 
between mood, anxiety, motivation (RCQ[TV]) and relapse. Logistic regression revealed no 




2.5.2 Interpretation of Findings – Normative Data 
The finding that the current clinical sample performed below a healthy control sample on 
the ACE-III cognitive screen is unsurprising. What makes this more striking is that the 
comparison group were, on average, twenty years older than the clinical sample presented 
here. A strong body of research would suggest that AD individuals consistently exhibit 
cognitive impairment compared to their peers on a wide variety of neuropsychological 
functions (Parsons, 1998). These deficits tend to be most apparent in the areas of memory 
and visuospatial functioning, which is consistent with the current findings. However, 
language abilities tend to be relatively well preserved in alcohol-dependence (Hartman, 
1995; cited in Hazelton, 2003) and, in this sample, language performance fell significantly 
below what might be expected. Despite its ability to briefly measure a wide variety of 
domains of cognitive functioning, the ACE-III is heavily weighted towards tasks of language 
ability (Hsieh et al., 2013). Therefore, it is surprising that the current sample exhibited 
marked impairment in this area.  
 
It is possible that the early stage of assessment in this study uncovered a profile of 
difficulties that are present in the earlier stages of abstinence and differ from that in longer-
term abstinence. The ACE-III was administered between seven and eleven days in the 
current study, falling far short of the recommended three-week minimum. Therefore it is 
likely that the assessment picked up a degree of residual impairment owing to prior 
intoxication and the detoxification process itself. The reducing regime of benzodiazepine 
therapy during detoxification is adjusted according to the needs of the individual and 
therefore, at the time of the cognitive screen, it is possible that participants were at varying 
degrees of abstinence from prescribed medication. Benzodiazepines are known, in 
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particular, to reduce memory and learning ability (Stewart, 2005) alongside having the 
effect of sedation. It is possible that this and concurrent drug use in a proportion of the 
sample contributed to the profile of impairment observed. 
 
Whilst no formal measure of dependence severity was used, it is likely that the majority of 
participants in this study would fall within the severe range. Furthermore, since no measure 
of premorbid functioning was used, it is possible that overall intellectual ability was lower in 
this sample. Illiteracy levels tend to be higher within substance-using populations than in 
the general population and this may go some way to explaining the reduced performance in 
tasks of language functioning. The purpose of presenting a normative dataset was to allow 
for clinical comparisons of ACE-III performance in a severely alcohol dependent population 
in the early stages following detoxification. Whilst limited in their generalisability beyond 
this population, it is hoped that the presented data allow for more meaningful comparisons 
in this particular client group. 
 
2.5.3 Interpretation of Findings – Predictors of Outcome 
The findings from the current study do not support the idea that ACE-III scores predict 
relapse. However, it is important to bear in mind the low sample size and consequent low 
power achieved in the statistical analyses involved in this part of the study (see section 
2.5.4 below for discussion of implications). This is surprising in the context of a large body 
of research supporting a relationship between cognitive functioning and treatment 
outcomes in addictions. One possible reason for this discrepancy is the choice of measure 
of cognitive functioning. Whilst the ACE-III has been recommended for use in the alcohol 
dependent population, its suitability for assessing alcohol-related cognitive impairment has 
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not been investigated. Alcohol dependent populations tend to show marked impairment on 
tests of executive functioning, even in the absence of other neuropsychological and 
functional impairment (Moselhy et al., 2001). This was reflected in the current sample by 
scores averaging more than two standard deviations below the normative mean for the 
verbal fluency domain. This domain however, is the only one in the ACE-III thought to rely 
substantially on executive functioning and its relative contribution to the overall score is 
small (14 of 100 possible points). Given the prevalence of executive dysfunction in this 
population and the likely impact of this on ability to engage in psychosocial interventions, it 
would be of relevance to consider cognitive screening tools which place more emphasis on 
this particular area of functioning. Furthermore, executive functions are believed to serve 
the role of overseeing and controlling the primary cognitive functions (Stuss, 2011). From 
this perspective, it is possible that some degree of impairment across tasks of other 
domains of functioning may result from executive functioning deficits rather than domain-
specific deficits. A study of neuropsychological functioning and relapse in a similar 
population to the current study identified that executive dysfunction during detoxification 
successfully predicted number of days drinking at three months post-discharge (Morrison, 
2011). A systematic review of risk factors for drop-out from treatment in addictions also 
highlighted that executive functioning deficits were often what distinguished those who 
engaged with treatment from those who did not (Brorson et al., 2013). These findings 
highlight the need to include a measure sensitive to such functioning in any assessment of 
alcohol-related cognitive impairment. 
 
Another aspect of the current study which may have resulted in finding no relationship 
between ACE-III score and outcome was the method of recording follow up. Owing to 
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limited information available, the outcome variable of relapse was dichotomised to allow 
for retention of data. The normative data presented for this clinical sample demonstrated a 
greater degree of variance in ACE-III scores compared to the healthy comparison group, 
highlighting heterogeneity amongst substance-misusing populations. Miller et al. (2001) 
caution against dichotomising relapse data, as it does not take into account the degree of 
improvement often seen in a proportion of people who do not maintain abstinence but also 
do not return to drinking at their previous level. By reducing the outcome measure in this 
way, any relationship between cognitive functioning and outcome may have been 
obscured. 
 
Finally, the current study examined the relationship between cognitive functioning and 
outcome in only severely alcohol dependent individuals. Whilst helping to create a ‘purer’ 
sample which, it was hoped, could be more comparable to similar clinical populations, it is 
acknowledged that such sampling may have limited the applicability of the research into 
outcomes which informed the current study. Of the 11 studies reviewed in relation to 
cognitive functioning and drop-out, Brorson et al. (2013) reported significant relationships 
in all of them. However, none of these reported on an alcohol dependent sample – five 
reported on mixed substance-use disorders, one on marijuana, four on cocaine and one on 
heroin and crack cocaine. Adamson et al. (2009) systematically reviewed the literature for 
predictors of alcohol treatment outcome and found neuropsychological functioning to be a 
moderate predictor, however they stated that the neuropsychological variables varied too 
much to draw any meaningful summary. These findings would suggest that the predictive 
capacity of cognitive functioning in ‘pure’ alcohol-dependence is not as clearly defined as in 
65 
 
wider substance-using populations. Furthermore, means of successfully capturing this 
impairment have not been clearly defined.  
 
2.5.4 Limitations  
One of the key limitations was sample size, particularly in relation to part II. Although it is 
tempting to suggest that a larger sample size may unearth a significant finding, none of the 
predictor variables in the analyses were even approaching significance. However, it is 
possible that reduced statistical power has prevented observation of trends toward 
significance which might otherwise have been apparent with a larger dataset. At the very 
least, with increased power it would have been possible to have greater confidence in the 
accuracy of the outcomes obtained in the current study. In addition, methods for collecting 
some of the information have added a considerable degree of confound to the data; for 
example, broad inclusion criteria and relying on key worker feedback to assess for relapse. 
Nonetheless, the large proportion of missing data in the current service evaluation serves 
to highlight the need for good quality recording of clinical information.  
 
Whilst keyworkers supplied a reasonable degree of information, a high volume of missing 
data resulted in the loss of datasets and the eventual digression towards a dichotomous 
variable. This was particularly evident in relation to information on engagement with 
treatment. It may be that by including more assertive follow-up techniques, such as those 
suggested by the developers of the Addiction Severity Index (‘Addiction Severity Index 
Manual and Question by Question Guide’, The University of Pennsylvania, n.d.), and 
acknowledging the follow-up input of a wider range of supports and services, more 




2.5.5 Implications for Research 
With the advent of the notion of ‘recovery capital’ – the sum of internal and external 
resources that can be drawn on by the individual to initiate and sustain recovery – , the 
potential value of social and mutual aid supports has become apparent in the field of 
addictions research (Best & Laudet, n.d.). Future research may benefit from including such 
variables and considering wider factors in addition to patient-specific variables, as 
suggested by Brorson et al. (2013). The current study included five predictor variables; 
however it is important to note that other variables have been demonstrated to contribute 
to treatment outcomes. These include – but are not restricted to – dependence severity, 
psychopathology, alcohol-related self-efficacy and treatment goal (Adamson et al., 2009); 
treatment alliance and personality (Brorson et al., 2013).  It seems relevant to suggest that 
efforts go into separating those factors which are specific to alcohol dependent populations 
and working towards conceptual clarity and consistency of measurement and reporting of 
variables. In a population such as alcohol-dependency, which is so heterogeneous in nature, 
such methodological aspects become ever-more important to allow for meaningful 
interpretation of findings.  
 
2.5.6 Implications for Clinical Practice 
The findings highlight the need for a comprehensive assessment of cognitive functioning to 
inform treatment planning, with adequate emphasis placed on assessment of executive 
functions. It is clear from the normative data that in the early stages following 
detoxification, severely alcohol dependent individuals are likely to exhibit a substantial 
degree of cognitive impairment. The implications in terms of engaging with psychosocial 
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interventions are clear and it is important that treatment providers consider this in the 
planning and delivery of services for this population.  
 
A recent systematic review by Svanberg and Evans (2013) outlined the evidence-base for 
the rehabilitation of alcohol-related brain damage, including executive dysfunction. If 
alcohol dependent individuals are to engage with and benefit from evidence-based psycho-
social interventions, it is suggested that treatment programmes for such populations 
incorporate strategies for cognitive rehabilitation. This should also take into account 
adequate modification of patient environments to account for some of the difficulties this 
population face, such as clear signage to assist with orientating to a new environment. It is 
also suggested that if clinical populations such as the one accessed for the current study are 
to benefit from treatment, perhaps longer periods in contact with services with more 
intensive support will be required. Alcohol-related brain damage is sometimes referred to 
as ‘alcoholic dementia’ (see Moriyama et al., 2006). Older adult services in the UK often 
adopt a tiered service model, including day services for people with dementia. Perhaps 
then, given the degree of overlap in presentations between older adult dementia 
populations and alcohol dependent individuals, such models could afford a degree of 




The current study identified a substantial degree of global cognitive impairment in a 
severely alcohol dependent population in the early stages following inpatient detoxification 
though this impairment was not found to be predictive of relapse at one-month following 
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discharge. Methods for recording outcome variables may have reduced the quality of this 
study. It is also noted that the ACE-III may not be sensitive to profile of impairment in this 
population. It is suggested that future research focus on identifying the factors specific to 
alcohol dependent individuals in relation to relapse, taking into account factors in addition 
to patient-related variables. Furthermore treatment providers should consider routinely 
assessing cognitive impairment in this population and tailor their input accordingly, both at 
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APPENDIX 2.  MEASURING OUTCOMES IN THE IOWA GAMBLING TASK (IGT) 
 
 
The Iowa Gambling task offers the researcher or clinician a variety of options for measuring 
outcome. Perhaps the most commonly cited in the research literature is net outcome for 
the total task (either monetary amount at end of task, number of cards picked from 
advantageous decks, or number of cards picked from advantageous decks minus those 
from disadvantageous ones). This measure allows for an overall estimation of the 
participant’s decision-making ability taking the task as a whole (e.g. across the full 100 card 
selections). The benefits of this approach include that it allows for a simple judgement of an 
individual’s ability and easy comparison of outcomes between groups of participants (see 
reviewed articles for examples). One clear disadvantage of this outcome measure however, 
is the lack of detail regarding choice behaviour over time.  
 
Another common outcome measure derived from the IGT is to consider participants’ 
performance at different temporal stages of the task (e.g. across each of the five blocks of 
20 card selections or comparing early versus late stages). Similar to the net outcome 
approach, this can take the form of number of choices from advantageous minus 
disadvantageous decks within any given block. This particular method has been adopted 
widely in the literature examining IGT performance and yields some clear benefits over the 
total net score alone. Firstly, it allows the examiner to observe any patterns in performance 
across the task. Bechara, Tranel and Damasio (2000)1 describe the implicit learning evident 
in healthy ‘normal’ individuals as demonstrated by an eventual shift towards so-called 
advantageous decks. By examining different stages of the task, the researcher may begin to 
see patterns of responding that give clues to the decision-making behaviour of the 
participant over time. Subsequently, this allows for consideration of the constituent 
processes at play throughout the different stages of the task. Given the known impact of 
alcohol-dependence on memory and aspects of learning, this would be of particular 
relevance to studies of any such populations and therefore has been included in the current 
review where this information was available. 
 
In addition to the above outcome measures, many investigators have attempted to assess 
implicit ‘learning’ in the IGT. Dunn et al. (2006)2 provide a critical evaluation of so-called 
‘somatic markers’ where performance on the IGT is linked to autonomic physiological 
responses (skin conductance), which are thought to indicate the anticipation of failure or 
punishment on the task and tend to be absent in people with damage to the ventromedial 
prefrontal cortex. It is commonly accepted that, as the IGT progresses, participants gain 
more explicit or conceptual knowledge of the reward schedules of each deck (see Brand et 
al., 2007)3. Continuing to make disadvantageous decisions in the latter stages of the IGT is 
                                                          
1 Bechara, A., Tranel, D. & Damasio, H. (2000). Characterization of the decision-making deficit of patients with ventromedial 
prefrontal cortex lesions. Brain, 123, 2189-2202. 
2 Dunn, B. D., Dalgleish, D. & Lawrence, A. D. (2006). The somatic marker hypothesis: A critical evaluation. Neuroscience and 
Behavioral Reviews, 30, 239-271. 
 
3 Brand, M., Recknor, E. C., Grabenhorst, F., Bechara, A., 2007. Decisions under ambiguity and decisions under risk: 
Correlations with executive functions and comparisons of two different gambling tasks with implicit and explicit rules. Journal 
of Clinical and Experimental Neuropsychology. 29(1), 86-9 
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often considered ‘risky’ decision-making, owing to the assumed knowledge of the risks 
related to such choice behaviour. However, much debate exists in the research literature 
regarding the underlying processes of such behaviour owing to the low specificity of the IGT 
in this regard (Brand et al., 2007). Aspects of implicit learning were not directly related to 




APPENDIX 3. TABLE OF EXCLUDED PAPERS 
 
  
Study Reason(s) for exclusion 
Alfonso et al. (2011) Mixed substance-use disorder (SUD) group (alcohol, cocaine, cannabis) 
Andrade & Petry (2012) Mixed SUD group and <100% of those using alcohol met criteria for alcohol-
dependence (AD) 
Ashenhurst, Jentsch & Ray (2011) Alcohol Use Disorder (AUD) group mixed AD  (72.3%) and ‘problematic 
drinkers’ 
Barry & Petry (2008) Mixed SUD group 
Bechara et al. (2001) Mixed SUD group 
Bishara et al. (2009) No alcohol group 
Bjork et al. (2008) Alcohol patients co-dependent on/using 1 or more other substances 
Bjork, Smith & Hommer (2008) Alcohol patients co-dependent on/using 1 or more other substances 
Boettiger et al. (2007) Explicit decision-making (DM) measure used 
Brand et al. (2005) Explicit DM measure used 
Brand et al. (2009) Explicit DM measure used 
Campbell, Samartgis & Crowe (2013) SUD status (other than alcohol) not reported/excluded 
Cantrell et al. (2008) History of substance-use other than alcohol in AD group 
Chanraud et al. (2007) No DM measure 
Claus & Hutchison (2012) Only 74% of AUD group met criteria for AD 
Corbin & Cronce (2007) Alcohol sample not assessed to have AD 
Explicit DM measure used 
Courtney et al. (2012) Only 71.9% of AUD group met criteria for AD 
Dao-Castellana et al. (1998) No DM measure 
Demir et al. (2002) No DM measure 
De Wilde et al. (2013a) AUD group polysubstance-dependent on at least three other substances 
De Wilde et al. (2013b) AUD group polysubstance-dependent on at least three other substances 
Dom et al. (2006a) History of polysubstance use/dependence in AUD sample 
Dom et al. (2006b) History of polysubstance use/dependence in AUD sample 
Dom et al. (2007) History of polysubstance use/dependence in AUD sample 
Durazzo et al. (2006) No DM measure 
Fein et al. (2006) Duplicate IGT results – already reported in Fein, Klein & Finn (2004) 
Fernandez-Serrano et al. (2010) Mixed SUD group 
Fishbein et al. (2007) Explicit DM measure used 
Flannery et al. (2007) Explicit DM measure used 
Fridberg, Gerst & Finn (2013) Mixed SUD group 
Fukunara et al. (2013) Mixed SUD group 
Gansler et al. (2000) No DM measure 
Georgemiller et al. (2013) Proportion of AD subjects exhibited polysubstance dependence 
Gonzalez, Bechara & Martin (2007) History of polysubstance use/dependence in AUD sample 
Gullo & Stieger (2011) AUD group not dependent 
Harvanko et al. (2012) Alcohol abuse and AD combined into one category 
Hildebrandt et al. (2006) Substance-use status of AD group not explicitly addressed 
Jokisch et al. (2014)  No explicit exclusion of polysubstance use/dependence 
Jollant et al. (2007) High psychiatric comorbidity in sample 
Mixed SUD 
Kamarajan et al. (2012) AD sample known to include participants with comorbid drug abuse 
Lawrence et al. (2009) Explicit DM measure used 
Lee et al. (2013) DM measured in terms of reaction time rather than risky performance 
Luhar et al. (2013) No DM measure 
Mazas, Finn & Steinmetz (2000) History of substance-use other than alcohol in AD group 
Mitchell et al. (2005) Explicit DM measure used 
Mitchell et al. (2007) Explicit DM measure used 
Rustemeier et al. (2014) Explici DM measure used 
Stojek et al. (2014) Explicit DM measure used 
Stout et al. (2005) Mixed SUD group 
Tanabe et al. (2013) Mixed SUD group 
Van der Plas et al. (2009) Occasional other substance use in proportion of AD group 
Vanes et al. (2014) Explicit DM measure used 
Yechiam et al. (2008) No alcohol group 
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Scoring criteria:  
Yes = 1 point,No/Unclear = 0 
Item Score 
1. The study context and rationale is clear  
2. The aims of the study are specific and appropriate  
Participants 
3. Recruitment strategy is clearly defined   
4. Ethical considerations are described (including informed consent)  
5. ‘Caseness’ of participants is clearly defined  
6. Control group included  
7. Exclusion criteria are clear and applied to both cases and controls, 
where applicable 
 




9. Methods clearly described to allow for replication  
10. Potential confounding factors are acknowledged and adequately 
controlled for in the design and analysis 
 
Analysis and Results 
11. Descriptive statistics are presented  
12. A priori sample size calculation described  
13. Analysis is appropriate to the research aims  
14. Effect sizes are reported for measures of decision-making  




16. Results are clearly summarised in relation to the original 
aims/hypotheses 
 
17. Any conclusions are consistent with the results of the study and 
substantiated with relevant evidence 
 
18. Issues of generalisability and implications of the research are 
discussed 
 
19. Limitations are acknowledged  
 




APPENDIX 5. QUALITY RATINGS TABLE 













































Ando et al. (2012) + ? ? + + - + + ? ? ? - + - - + + + + 10 
Bowden-Jones et al. (2005) + + ? + + + ? ? ? - + - + - - + + + - 10 
Brevers et al. (2014) + + ? + + + ? ? + + + - + + - + + ? - 12 
Cordovil De Sousa Uva et al. (2010) + + + + + + ? + + + + - + + - + + + + 16 
Fein, Klein  Finn (2004) + + + + + + + + + + + - + - - + - + + 15 
Fein, McGillivray & Finn (2006) + + + + + + + + ? + + - + - - + + + + 15 
Goudriaan et al. (2005) + + - + + + ? ? + + ? - + + - + + + + 13 
Kim, Lee & Kim (2006) + + ? + + + + ? ? - + - ? - - + ? - + 9 
Kim, Sohn & Jeong (2011) + + ? + + + + + + + + - + ? - + + - + 14 
Le Berre et al (2014) + + ? + + + ? + + + ? - + - - + + + + 13 
Loeber et al (2009) + + ? + + + + + ? - + - + - - + + - + 12 
Miranda et al (2009) + + + + + + + + ? + + - + + - + + + + 16 
Noel et al (2007) + + ? + + + ? + + ? ? - + + - + + - + 12 
Noel et al (2011) + + ? + + + ? + ? - + - + - - + + + + 12 
Salgado et al (2009) + + ? + + + + + + + + - + - - + + + + 15 
Tomassini et al (2012) + + ? + + + - - ? + + - + - - + + ? + 11 
Zorlu et al (2013a) + + ? + + + + + ? ? + - + - - + + + + 13 
Zorlu et al (2013b) + + ? + + + ? + + + + - + - - + + + + 14 
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